Cardinal Point Capital Management ULC acquired a new position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 6,822 shares of the company's stock, valued at approximately $1,087,000.
Other large investors have also modified their holdings of the company. Nova Wealth Management Inc. purchased a new stake in shares of Procter & Gamble during the first quarter worth $26,000. Signature Resources Capital Management LLC increased its position in shares of Procter & Gamble by 67.9% during the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock worth $28,000 after acquiring an additional 72 shares during the period. Quarry LP acquired a new position in shares of Procter & Gamble during the first quarter worth $33,000. Mid American Wealth Advisory Group Inc. acquired a new position in shares of Procter & Gamble during the second quarter worth $34,000. Finally, RMG Wealth Management LLC acquired a new position in shares of Procter & Gamble during the second quarter worth $37,000. Hedge funds and other institutional investors own 65.77% of the company's stock.
Insider Activity
In other news, CFO Andre Schulten sold 4,252 shares of the business's stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $647,281.96. Following the completion of the sale, the chief financial officer owned 53,992 shares of the company's stock, valued at approximately $8,219,202.16. The trade was a 7.30% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jennifer L. Davis sold 3,227 shares of the stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $491,246.21. Following the transaction, the chief executive officer directly owned 61,764 shares in the company, valued at $9,402,333.72. The trade was a 4.97% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock worth $23,421,279 over the last three months. 0.20% of the stock is currently owned by corporate insiders.
Procter & Gamble Price Performance
PG stock opened at $152.20 on Friday. Procter & Gamble Company has a 12 month low of $146.96 and a 12 month high of $180.43. The company's 50 day simple moving average is $154.69 and its 200-day simple moving average is $158.44. The firm has a market capitalization of $356.22 billion, a PE ratio of 23.38, a P/E/G ratio of 4.04 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The firm had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. Procter & Gamble's revenue was up 1.7% compared to the same quarter last year. During the same quarter last year, the business earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be paid a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 annualized dividend and a yield of 2.8%. Procter & Gamble's payout ratio is 64.82%.
Wall Street Analyst Weigh In
PG has been the subject of a number of analyst reports. Bank of America lowered their target price on shares of Procter & Gamble from $180.00 to $174.00 and set a "buy" rating for the company in a research note on Wednesday, October 8th. UBS Group lowered their target price on shares of Procter & Gamble from $180.00 to $176.00 and set a "buy" rating for the company in a research note on Wednesday, October 8th. Evercore ISI reiterated an "in-line" rating and set a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Berenberg Bank upped their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a research note on Wednesday, September 17th. Finally, BNP Paribas Exane decreased their price objective on shares of Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating for the company in a research note on Tuesday, September 23rd. Eleven analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $171.68.
Read Our Latest Analysis on PG
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.